William John Scheessele - Jan 21, 2025 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Signature
/s/ William John Scheessele by Dale A. Sander as Attorney-in-Fact
Stock symbol
HUMA
Transactions as of
Jan 21, 2025
Transactions value $
$0
Form type
4
Date filed
1/23/2025, 04:34 PM
Previous filing
Dec 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The first 25% of the option becomes exercisable on January 21, 2026, after which 1/48 of the option will become exercisable on the 21st of each month through January 21, 2029.